RTS,S (Italian Wikipedia)

Analysis of information sources in references of the Wikipedia article "RTS,S" in Italian language version.

refsWebsite

Global rank Italian rank

15doi.org

2^nd place

7^th place

10oadoi.org

799^th place

22^nd place

9nih.gov

4^th place

9^th place

4web.archive.org

1^st place

3who.int

195^th place

342^nd place

2plos.org

2,112^th place

2,144^th place

1patents.google.com

1,182^nd place

2,474^th place

1sciencedirect.com

149^th place

298^th place

1theguardian.com

12^th place

32^nd place

1nytimes.com

7^th place

19^th place

1aljazeera.com

268^th place

631^st place

1nejm.org

2,374^th place

1,283^rd place

1washingtonpost.com

34^th place

116^th place

1nature.com

234^th place

226^th place

aljazeera.com

(EN) Could new vaccines end malaria in Africa?, su aljazeera.com. URL consultato il 15 gennaio 2024.

doi.org

dx.doi.org

Regules JA, Cummings JF, Ockenhouse CF, The RTS,S vaccine candidate for malaria, in Expert Review of Vaccines, vol. 10, n. 5, maggio 2011, pp. 589–99, DOI:10.1586/erv.11.57, PMID 21604980.
(EN) D. Gray Heppner, Kent E. Kester e Christian F. Ockenhouse, Towards an RTS,S-based, multi-stage, multi-antigen vaccine against falciparum malaria: progress at the Walter Reed Army Institute of Research, in Vaccine, vol. 23, n. 17, 18 marzo 2005, pp. 2243–2250, DOI:10.1016/j.vaccine.2005.01.142. URL consultato l'11 ottobre 2021.
Hill AV, Vaccines against malaria, in Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences, vol. 366, n. 1579, ottobre 2011, pp. 2806–14, DOI:10.1098/rstb.2011.0091, PMID 21893544.
Graves P, Gelband H, Vaccines for preventing malaria (SPf66), in The Cochrane Database of Systematic Reviews, n. 2, aprile 2006, pp. CD005966, DOI:10.1002/14651858.CD005966, PMID 16625647.
Graves P, Gelband H, Vaccines for preventing malaria (blood-stage), in The Cochrane Database of Systematic Reviews, n. 4, ottobre 2006, pp. CD006199, DOI:10.1002/14651858.CD006199, PMID 17054281.
Graves P, Gelband H, Vaccines for preventing malaria (pre-erythrocytic), in The Cochrane Database of Systematic Reviews, n. 4, ottobre 2006, pp. CD006198, DOI:10.1002/14651858.CD006198, PMID 17054280.
Fractional Third and Fourth Dose of RTS,S/AS01 Malaria Candidate Vaccine: A Phase 2a Controlled Human Malaria Parasite Infection and Immunogenicity Study, vol. 214, settembre 2016, DOI:10.1093/infdis/jiw237, PMID 27296848.
(EN) Daniel Chandramohan, Issaka Zongo e Issaka Sagara, Seasonal Malaria Vaccination with or without Seasonal Malaria Chemoprevention, in New England Journal of Medicine, 25 agosto 2021, DOI:10.1056/NEJMoa2026330. URL consultato l'11 ottobre 2021.
Heppner DG, Kester KE, Ockenhouse CF, Tornieporth N, Ofori O, Lyon JA, Stewart VA, Dubois P, Lanar DE, Krzych U, Moris P, Angov E, Cummings JF, Leach A, Hall BT, Dutta S, Schwenk R, Hillier C, Barbosa A, Ware LA, Nair L, Darko CA, Withers MR, Ogutu B, Polhemus ME, Fukuda M, Pichyangkul S, Gettyacamin M, Diggs C, Soisson L, Milman J, Dubois MC, Garçon N, Tucker K, Wittes J, Plowe CV, Thera MA, Duombo OK, Pau MG, Goudsmit J, Ballou WR, Cohen J, Towards an RTS,S-based, multi-stage, multi-antigen vaccine against falciparum malaria: progress at the Walter Reed Army Institute of Research, in Vaccine, vol. 23, 17–18, marzo 2005, pp. 2243–50, DOI:10.1016/j.vaccine.2005.01.142, PMID 15755604.
Rutgers T, Gordon D, Gathoye AM, Hollingdale M, Hockmeyer W, Rosenberg M, De Wilde M, Hepatitis B Surface Antigen as Carrier Matrix for the Repetitive Epitope of the Circumsporozoite Protein of Plasmodium Falciparum., in Nature Biotechnology, vol. 6, n. 9, settembre 1988, pp. 1065–1070, DOI:10.1038/nbt0988-1065.
RTS,S Clinical Trials Partnership, Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial, vol. 386, DOI:10.1016/S0140-6736(15)60721-8, PMID 25913272.
(EN) Kristian E. Swearingen, Scott E. Lindner e Lirong Shi, Interrogating the Plasmodium Sporozoite Surface: Identification of Surface-Exposed Proteins and Demonstration of Glycosylation on CSP and TRAP by Mass Spectrometry-Based Proteomics, in PLOS Pathogens, vol. 12, n. 4, 29 aprile 2016, pp. e1005606, DOI:10.1371/journal.ppat.1005606. URL consultato l'11 ottobre 2021.
(EN) Sash Lopaticki, Annie S. P. Yang e Alan John, Protein O-fucosylation in Plasmodium falciparum ensures efficient infection of mosquito and vertebrate hosts, in Nature Communications, vol. 8, n. 1, 15 settembre 2017, pp. 561, DOI:10.1038/s41467-017-00571-y. URL consultato l'11 ottobre 2021.
(EN) Kristian E. Swearingen, Scott E. Lindner e Erika L. Flannery, Proteogenomic analysis of the total and surface-exposed proteomes of Plasmodium vivax salivary gland sporozoites, in PLOS Neglected Tropical Diseases, vol. 11, n. 7, 31-lug-2017, pp. e0005791, DOI:10.1371/journal.pntd.0005791. URL consultato l'11 ottobre 2021.
Vaccine-induced monoclonal antibodies targeting circumsporozoite protein prevent Plasmodium falciparum infection, vol. 124, DOI:10.1172/JCI70349, PMID 24292709.

nature.com

(EN) Sash Lopaticki, Annie S. P. Yang e Alan John, Protein O-fucosylation in Plasmodium falciparum ensures efficient infection of mosquito and vertebrate hosts, in Nature Communications, vol. 8, n. 1, 15 settembre 2017, pp. 561, DOI:10.1038/s41467-017-00571-y. URL consultato l'11 ottobre 2021.

nejm.org

(EN) Daniel Chandramohan, Issaka Zongo e Issaka Sagara, Seasonal Malaria Vaccination with or without Seasonal Malaria Chemoprevention, in New England Journal of Medicine, 25 agosto 2021, DOI:10.1056/NEJMoa2026330. URL consultato l'11 ottobre 2021.

nih.gov

ncbi.nlm.nih.gov

Regules JA, Cummings JF, Ockenhouse CF, The RTS,S vaccine candidate for malaria, in Expert Review of Vaccines, vol. 10, n. 5, maggio 2011, pp. 589–99, DOI:10.1586/erv.11.57, PMID 21604980.
Hill AV, Vaccines against malaria, in Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences, vol. 366, n. 1579, ottobre 2011, pp. 2806–14, DOI:10.1098/rstb.2011.0091, PMID 21893544.
Graves P, Gelband H, Vaccines for preventing malaria (SPf66), in The Cochrane Database of Systematic Reviews, n. 2, aprile 2006, pp. CD005966, DOI:10.1002/14651858.CD005966, PMID 16625647.
Graves P, Gelband H, Vaccines for preventing malaria (blood-stage), in The Cochrane Database of Systematic Reviews, n. 4, ottobre 2006, pp. CD006199, DOI:10.1002/14651858.CD006199, PMID 17054281.
Graves P, Gelband H, Vaccines for preventing malaria (pre-erythrocytic), in The Cochrane Database of Systematic Reviews, n. 4, ottobre 2006, pp. CD006198, DOI:10.1002/14651858.CD006198, PMID 17054280.
Fractional Third and Fourth Dose of RTS,S/AS01 Malaria Candidate Vaccine: A Phase 2a Controlled Human Malaria Parasite Infection and Immunogenicity Study, vol. 214, settembre 2016, DOI:10.1093/infdis/jiw237, PMID 27296848.
Heppner DG, Kester KE, Ockenhouse CF, Tornieporth N, Ofori O, Lyon JA, Stewart VA, Dubois P, Lanar DE, Krzych U, Moris P, Angov E, Cummings JF, Leach A, Hall BT, Dutta S, Schwenk R, Hillier C, Barbosa A, Ware LA, Nair L, Darko CA, Withers MR, Ogutu B, Polhemus ME, Fukuda M, Pichyangkul S, Gettyacamin M, Diggs C, Soisson L, Milman J, Dubois MC, Garçon N, Tucker K, Wittes J, Plowe CV, Thera MA, Duombo OK, Pau MG, Goudsmit J, Ballou WR, Cohen J, Towards an RTS,S-based, multi-stage, multi-antigen vaccine against falciparum malaria: progress at the Walter Reed Army Institute of Research, in Vaccine, vol. 23, 17–18, marzo 2005, pp. 2243–50, DOI:10.1016/j.vaccine.2005.01.142, PMID 15755604.
RTS,S Clinical Trials Partnership, Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial, vol. 386, DOI:10.1016/S0140-6736(15)60721-8, PMID 25913272.
Vaccine-induced monoclonal antibodies targeting circumsporozoite protein prevent Plasmodium falciparum infection, vol. 124, DOI:10.1172/JCI70349, PMID 24292709.

nytimes.com

A 'Historical Event': First Malaria Vaccine Approved by W.H.O., in New York Times, 6 ottobre 2021. URL consultato il 6 ottobre 2021.

oadoi.org

Regules JA, Cummings JF, Ockenhouse CF, The RTS,S vaccine candidate for malaria, in Expert Review of Vaccines, vol. 10, n. 5, maggio 2011, pp. 589–99, DOI:10.1586/erv.11.57, PMID 21604980.
Hill AV, Vaccines against malaria, in Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences, vol. 366, n. 1579, ottobre 2011, pp. 2806–14, DOI:10.1098/rstb.2011.0091, PMID 21893544.
Graves P, Gelband H, Vaccines for preventing malaria (SPf66), in The Cochrane Database of Systematic Reviews, n. 2, aprile 2006, pp. CD005966, DOI:10.1002/14651858.CD005966, PMID 16625647.
Graves P, Gelband H, Vaccines for preventing malaria (blood-stage), in The Cochrane Database of Systematic Reviews, n. 4, ottobre 2006, pp. CD006199, DOI:10.1002/14651858.CD006199, PMID 17054281.
Graves P, Gelband H, Vaccines for preventing malaria (pre-erythrocytic), in The Cochrane Database of Systematic Reviews, n. 4, ottobre 2006, pp. CD006198, DOI:10.1002/14651858.CD006198, PMID 17054280.
Fractional Third and Fourth Dose of RTS,S/AS01 Malaria Candidate Vaccine: A Phase 2a Controlled Human Malaria Parasite Infection and Immunogenicity Study, vol. 214, settembre 2016, DOI:10.1093/infdis/jiw237, PMID 27296848.
Heppner DG, Kester KE, Ockenhouse CF, Tornieporth N, Ofori O, Lyon JA, Stewart VA, Dubois P, Lanar DE, Krzych U, Moris P, Angov E, Cummings JF, Leach A, Hall BT, Dutta S, Schwenk R, Hillier C, Barbosa A, Ware LA, Nair L, Darko CA, Withers MR, Ogutu B, Polhemus ME, Fukuda M, Pichyangkul S, Gettyacamin M, Diggs C, Soisson L, Milman J, Dubois MC, Garçon N, Tucker K, Wittes J, Plowe CV, Thera MA, Duombo OK, Pau MG, Goudsmit J, Ballou WR, Cohen J, Towards an RTS,S-based, multi-stage, multi-antigen vaccine against falciparum malaria: progress at the Walter Reed Army Institute of Research, in Vaccine, vol. 23, 17–18, marzo 2005, pp. 2243–50, DOI:10.1016/j.vaccine.2005.01.142, PMID 15755604.
Rutgers T, Gordon D, Gathoye AM, Hollingdale M, Hockmeyer W, Rosenberg M, De Wilde M, Hepatitis B Surface Antigen as Carrier Matrix for the Repetitive Epitope of the Circumsporozoite Protein of Plasmodium Falciparum., in Nature Biotechnology, vol. 6, n. 9, settembre 1988, pp. 1065–1070, DOI:10.1038/nbt0988-1065.
RTS,S Clinical Trials Partnership, Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial, vol. 386, DOI:10.1016/S0140-6736(15)60721-8, PMID 25913272.
Vaccine-induced monoclonal antibodies targeting circumsporozoite protein prevent Plasmodium falciparum infection, vol. 124, DOI:10.1172/JCI70349, PMID 24292709.

patents.google.com

(EN) Michel De Wilde e Joseph Smithkline Beecham Biologicals S. A. Cohen, HYBRID PROTEIN BETWEEN CS FROM PLASMODIUM AND HBsAG, EP0614465B1, 17 marzo 1999. URL consultato l'11 ottobre 2021.

plos.org

journals.plos.org

(EN) Kristian E. Swearingen, Scott E. Lindner e Lirong Shi, Interrogating the Plasmodium Sporozoite Surface: Identification of Surface-Exposed Proteins and Demonstration of Glycosylation on CSP and TRAP by Mass Spectrometry-Based Proteomics, in PLOS Pathogens, vol. 12, n. 4, 29 aprile 2016, pp. e1005606, DOI:10.1371/journal.ppat.1005606. URL consultato l'11 ottobre 2021.
(EN) Kristian E. Swearingen, Scott E. Lindner e Erika L. Flannery, Proteogenomic analysis of the total and surface-exposed proteomes of Plasmodium vivax salivary gland sporozoites, in PLOS Neglected Tropical Diseases, vol. 11, n. 7, 31-lug-2017, pp. e0005791, DOI:10.1371/journal.pntd.0005791. URL consultato l'11 ottobre 2021.

sciencedirect.com

(EN) D. Gray Heppner, Kent E. Kester e Christian F. Ockenhouse, Towards an RTS,S-based, multi-stage, multi-antigen vaccine against falciparum malaria: progress at the Walter Reed Army Institute of Research, in Vaccine, vol. 23, n. 17, 18 marzo 2005, pp. 2243–2250, DOI:10.1016/j.vaccine.2005.01.142. URL consultato l'11 ottobre 2021.

theguardian.com

WHO endorses use of world's first malaria vaccine in Africa, in The Guardian, 6 ottobre 2021. URL consultato il 6 ottobre 2021.

washingtonpost.com

Experimental malaria vaccine protects many children, study shows, in Washington Post, 18 ottobre 2011.

web.archive.org

Malaria vaccine gets 'green light', BBC News, 24 luglio 2015. URL consultato il 25 luglio 2015 (archiviato dall'url originale il 21 luglio 2020).
Copia archiviata, su ema.europa.eu. URL consultato il 24 luglio 2015 (archiviato dall'url originale il 24 settembre 2018).
Copia archiviata, su blog.path.org. URL consultato l'11 ottobre 2021 (archiviato dall'url originale il 15 luglio 2017).
Trial suggests malaria sickness could be cut by 70%, BBC News, 26 agosto 2021. URL consultato il 26 agosto 2021 (archiviato dall'url originale il 3 ottobre 2021).

who.int

WHO recommends groundbreaking malaria vaccine for children at risk, su who.int.
WHO | MVIP countries: Ghana, Kenya and Malawi, su WHO. URL consultato l'11 ottobre 2021.
(EN) Malaria: The malaria vaccine implementation programme (MVIP), su who.int. URL consultato l'11 ottobre 2021.